Publikationen, an denen er mitarbeitet Francisco José Tinahones Madueño (44)

2022

  1. Adipose tissue and blood leukocytes ACE2 DNA methylation in obesity and after weight loss

    European Journal of Clinical Investigation, Vol. 52, Núm. 2

  2. DNA methylome in visceral adipose tissue can discriminate patients with and without colorectal cancer

    Epigenetics, Vol. 17, Núm. 6, pp. 665-676

  3. Immunomodulatory effect of a very-low-calorie ketogenic diet compared with bariatric surgery and a low-calorie diet in patients with excessive body weight

    Clinical Nutrition, Vol. 41, Núm. 7, pp. 1566-1577

  4. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

    Nutrients, Vol. 14, Núm. 1

2021

  1. An Epigenetic Signature is Associated with Serum 25-Hydroxyvitamin D in Colorectal Cancer Tumors

    Molecular Nutrition and Food Research, Vol. 65, Núm. 18

  2. Transdiagnostic perspective of impulsivity and compulsivity in obesity: From cognitive profile to self-reported dimensions in clinical samples with and without diabetes

    Nutrients, Vol. 13, Núm. 12

2020

  1. COVID Isolation Eating Scale (CIES): Analysis of the impact of confinement in eating disorders and obesity—A collaborative international study

    European Eating Disorders Review

2019

  1. Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative role as a mediator of decision-making

    Molecular and Cellular Endocrinology, Vol. 497

  2. Effect of a Very-Low-Calorie Ketogenic Diet on Circulating Myokine Levels Compared with the Effect of Bariatric Surgery or a Low-Calorie Diet in Patients with Obesity

    Nutrients, Vol. 11, Núm. 10

  3. Identification of an episignature of human colorectal cancer associated with obesity by genome-wide DNA methylation analysis

    International Journal of Obesity, Vol. 43, Núm. 1, pp. 176-188

  4. Novel SFRP2 DNA methylation profile following neoadjuvant therapy in colorectal cancer patients with different grades of BMI

    Journal of Clinical Medicine, Vol. 8, Núm. 7

  5. Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529

2017

  1. An increase in visceral fat is associated with a decrease in the taste and olfactory capacity

    PLoS ONE, Vol. 12, Núm. 2

  2. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

  3. Correction: An increase in visceral fat is associated with a decrease in the taste and olfactory capacity (PLoS ONE (2017) 12:2 (e0171204) DOI: 10.1371/journal.pone.0171204)

    PLoS ONE

  4. Obesity and menopause modify the epigenomic profile of breast cancer

    Endocrine-related cancer, Vol. 24, Núm. 7, pp. 351-363

  5. Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: A marker of metabolic stress?

    International Journal of Obesity, Vol. 41, Núm. 10, pp. 1570-1578

  6. Prevención, diagnóstico y tratamiento de la obesidad. Posicionamiento de la Sociedad Española para el Estudio de la Obesidad de 2016

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 15-22

2016

  1. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women

    PLoS ONE, Vol. 11, Núm. 2